NeuroMetrix

NURO NASDAQ
0.6400
+0.0049
+0.77%
Closed 16:00 05/21 EDT
Open
0.6500
Prev Close
0.6351
High
0.6800
Low
0.6237
Volume
50
Avg Vol (3M)
139.79K
52 Week High
1.770
52 Week Low
0.6000
% Turnover
3.14%
Market Cap
5.64M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers NeuroMetrix NURO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.
MORE >

Recently

Name
Price
%Change